The CRISPR babies controversy: Responsibility and regulation in the spotlight.
EMBO reports, 21(7): e50307 PMID 32468716 DOI 10.15252/embr.202050307
Abstract
The genome editing of human embryos by He Jianjui and the announcement to do so by Denis Rebrikov should spur the research community into discussing robust and transparent governance for human germline modificition.